Amber Bio is a San Francisco-based biotechnology company founded in 2021 that is pioneering RNA-based gene editing. Its multi-kilobase RNA writing platform is designed to correct thousands of diverse mutations across a patient population with a single product, rather than requiring an independent therapy for each separate mutation. - View it on GitHub